AOP Orphan Pharmaceuticals Competitors and Similar CompaniesClear all

AOP Orphan Pharmaceuticals's competitors and similar companies include Polymun, Zydus Lifesciences, Interbat and Aoxing Pharmaceutical.

	AOP Orphan Pharmaceuticals AOP Orphan is a company focused on clinical development, marketing and distribution of medicines for rare and complex diseases.	Polymun Polymun is a company specializing in contract development and manufacturing as well as creating liposomal formats of drugs for contract partners.	Zydus Lifesciences Zydus Lifesciences (formerly known as Cadila Healthcare) is a company that provides healthcare solutions.	Interbat Interbat is a pharmaceutical company.	Aoxing Pharmaceutical Aoxing Pharmaceutical is a specialty pharmaceutical company.
Founding Date	Founding Date 1996	Founding Date 1992	Founding Date 1952	Founding Date 1948	Founding Date 2002
Type	Type Private	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare distribution drug development pharma	Tags Healthcare biotech contractor drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma
Locations	Locations Wien, AT HQ Sofia, BG Meudon, FR Ismaning, DE Athina, GR Budapest, HU see more	Locations Klosterneuburg, AT HQ	Locations Ahmedabad, IN HQ Rio De Janeiro, BR Nanterre, FR Ahmedabad, IN Ambernath, IN Ankleshwar, IN Bengaluru, IN see more	Locations ID HQ	Locations Shijiazhuang Shi, CN HQ Shijiazhuang Shi, CN Foster City, US
Employees	Employees 5352% increase	Employees 80	Employees 27,9176% increase	Employees 9272% increase	Employees 346
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹267.2b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) $32.3m (FY, 2016)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹72.9b (FY, 2026)	Cost of goods N/A	Cost of goods $7.8m (FY, 2016)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹203.7b (FY, 2026)	Gross profit N/A	Gross profit $24.6m (FY, 2016)
Net income	Net income N/A	Net income N/A	Net income ₹50.3b (FY, 2026)	Net income N/A	Net income $2.1m (FY, 2016)